Female Hypoactive Sexual Desire Disorder Therapeutics Market Size And Share

  • Report Code : TIPRE00010487
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

여성 저활동성 성욕 장애 치료제 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Female Hypoactive Sexual Desire Disorder Therapeutics Market Report Analysis

Female Hypoactive Sexual Desire Disorder Therapeutics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Allergan plc
  • AMAG Pharmaceuticals, Inc.
  • Emotional Brain BV
  • Endoceutics, Inc.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • Palatin Technologies Inc
  • Pivot Pharmaceuticals Inc
  • Sprout Pharmaceuticals, Inc.

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 치료
  • 테스토스테론
  • 플리반세린
  • 부스피론
  • 부프로피온
  • 브레멜라노타이드
  • 인지 행동 치료
By 신청
  • 입원환자
  • 외래환자
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미